| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |